Loss of HLA Antigens in Colon Cancer
Author Information
Author(s): R.C. Rees, A.-M. Buckle, K. Gelsthorpe, V. James, C.W. Potter, K. Rogers, G. Jacob
Primary Institution: The University of Sheffield Medical School
Hypothesis
Does the expression of HLA antigens differ in colorectal carcinomas compared to normal colon tissue?
Conclusion
The study found that a significant portion of colorectal tumors exhibit a loss of specific HLA antigens, which may be associated with tumor differentiation and malignancy.
Supporting Evidence
- Approximately one third of colorectal tumors show reduced staining with W6/32 MAb.
- 44% of tumors expressed class II HLA antigens.
- Loss of HLA-A2 haplotype was shown in 4 of 15 tumor tissue samples.
- Loss of Bw4 specificities was shown in 5 out of 7 tissue samples.
- Most tumors showing loss of HLA determinants were classified as Dukes' stage B.
Takeaway
Some cancer cells in the colon don't show important markers that help the immune system recognize them, which might make the cancer worse.
Methodology
Patients undergoing surgery for colorectal adenocarcinoma provided tumor and normal colon tissue samples, which were analyzed for HLA antigen expression using monoclonal antibodies.
Limitations
The study did not establish a definitive correlation between loss of HLA expression and disease stage.
Participant Demographics
Patients undergoing laparotomy and resection of colorectal adenocarcinoma.
Want to read the original?
Access the complete publication on the publisher's website